Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RANBP2-like and GRIP domain-containing protein 8 (RGPD8) is a protein-coding gene located on human chromosome 2q14 and encodes a member of the tetratricopeptide repeat domain-containing family. It is predicted to bind small GTPases and contribute to GTPase activator activity, implicating a role in nuclear import processes, particularly the import of nuclear localization signal (NLS)-bearing proteins into the nucleus. RGPD8 is suggested to function as part of the nuclear pore complex and may be active in the cytoplasm. Although RGPD8 is structurally and functionally similar to RANBP2 (Nup358), there are no reports of RGPD8 as a therapeutic drug target, receptor, or established disease gene. Its principal biological roles are thought to relate to nucleocytoplasmic transport and intracellular protein complexes rather than direct involvement in signal transduction or disease pathophysiology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RANBP2-like and GRIP domain-containing protein 8 (RGPD8).